Steris (STE) Liabilities and Shareholders Equity (2018 - 2026)
Steris (STE) posted quarterly Liabilities and Shareholders Equity of $10.7 billion for Q1 2026, up 5.82% year-over-year from $10.1 billion in Q1 2025, and up 1.38% quarter-over-quarter from $10.6 billion in Q4 2025.
Steris (STE) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Steris' Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $10.7 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 5.82% year-over-year to $10.7 billion; the TTM figure through Mar 2026 stood at $42.1 billion (up 4.04% YoY), while the FY2026 annual figure was $10.7 billion, up 5.82% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $10.7 billion, up from $10.6 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $11.4 billion in Q4 2023, with the low at $10.0 billion in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $10.7 billion (2026), against an average of $10.7 billion.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 73.76% in 2022, then decreased 12.48% in 2024.
- Steris' Liabilities and Shareholders Equity stood at $10.8 billion in 2022, then advanced by 5.88% to $11.4 billion in 2023, then fell by 12.48% to $10.0 billion in 2024, then climbed by 5.83% to $10.6 billion in 2025, then advanced by 1.38% to $10.7 billion in 2026.
- Business Quant data shows STE's Liabilities and Shareholders Equity at $10.7 billion in Q1 2026, $10.6 billion in Q4 2025, and $10.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 22.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.74 Bn |
| Mar 31, 2026 | 10.74 Bn |
| Dec 31, 2025 | 10.59 Bn |
| Sep 30, 2025 | 10.41 Bn |
| Jun 30, 2025 | 10.41 Bn |
| Mar 31, 2025 | 10.15 Bn |
| Dec 31, 2024 | 10.01 Bn |
| Sep 30, 2024 | 10.24 Bn |
| Jun 30, 2024 | 10.11 Bn |
| Mar 31, 2024 | 11.06 Bn |
| Dec 31, 2023 | 11.44 Bn |
| Sep 30, 2023 | 11.28 Bn |
| Jun 30, 2023 | 10.78 Bn |
| Mar 31, 2023 | 10.82 Bn |
| Dec 31, 2022 | 10.80 Bn |
| Sep 30, 2022 | 10.49 Bn |
| Jun 30, 2022 | 11.19 Bn |
| Mar 31, 2022 | 11.42 Bn |
| Dec 31, 2021 | 11.69 Bn |
| Sep 30, 2021 | 11.75 Bn |